Biocon and Evotec enter strategic licensing agreement for biosimilar

Oct 14, 2019

Biocon and Evotec announce strategic licensing agreement for an early-stage biosimilar. Under this agreement, Biocon will take the asset through end-to-end development, IND filing, manufacturing and commercialisation and post-regulatory approval.

Print Page Mail Article